London-based Retroscreen Virology Raises £2.6M

Retroscreen Virology Limited, a London-based centre for antiviral and vaccine related research, has successfully raised £2.6m of equity funding from new investors.
The funding round was led by Aquarius Equity Partners Ltd in conjunction with IP Venture Fund.
As stated by John Lyon, Chairman of Retroscreen Virology Limited, the proceeds will be used to grow the business “ensuring that Retroscreen remains at the forefront of virology research and development”.

Join the discussion